APP Pharma Gets 2 FDA OKs for Generics (AP via Yahoo! Finance)
APP Pharmaceuticals Inc. said Friday federal regulators granted approvals to the company's versions of Bedford Laboratories' apnea drug Cafcit Oral Solution and Bristol-Myers Squibb Co.'s cancer treatment Blenoxane.

FDA caution, 'research drought' cuts drug approvals (USA Today)
Federal approvals of new drugs last year sank to the lowest in five years, a drop some industry analysts attribute to more cautious regulators and less innovation by drugmakers.